US 9375438
Inhibitors of NCCa-ATP channels for therapy
granted A61KA61K31/00A61K31/195
Quick answer
US patent 9375438 (Inhibitors of NCCa-ATP channels for therapy) held by The United States of America as Represented by the Dept. of Veterans Affairs expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Dept. of Veterans Affairs
- Grant date
- Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/00, A61K31/195, A61K31/198, A61K31/4453